• There is ongoing interest in developing more eCQMs for use in federal programs and obtaining NQF endorsement. However, developers have indicated that it can be challenging to test eCQMs to the extent necessary to meet NQF endorsement criteria – at least until they have been more widely implemented. NQF endorsement may provide the impetus to implement measures; but a submitted measure with very limited testing that does not meet NQF endorsement criteria could be prematurely abandoned.

    The Trial Approval Program is specifically for eCQMs that are ready for implementation, but cannot yet be adequately tested to meet NQF endorsement criteria. The program seeks to identify and support eCQMs that address important areas of performance measurement and quality improvement. As program participants, all eCQMs must be assessed as technically acceptable for implementation and have a plan to conduct more robust reliability and validity testing that takes advantage of clinical data in EHRs.

    Candidacy for the Trial Approval program is similar to eCQM endorsement candidacy and is reviewed by the standing committee based on the standard NQF evaluation criteria. Trial Approval carries no endorsement label, but may be considered a pathway for measures to prepare for endorsement. Trial Approval measures are indexed in QPS and are indicated as part of the program. See Table 12 (PDF) for comparison of activities related to endorsement and approved for Trial Use.

    Trial Approval Program Candidate Screening

    Candidates for the eCQM Trial Approval Program are initially screened by the NQF eCQM and Maintenance Measure Review team prior to standing committee review and consideration. Initial screening includes:

    • Must meet all criteria under Importance to Measure and Report (clinical evidence and opportunity for improvement/performance gap)
    • Completion of the submission form in the Measure Information Management System (MIMS)
    • Completion of the feasibility assessment
    • Completion of use results from either a simulated data set from the BONNIE Tool, or a test data set from another source to demonstrate that 100% of the measure logic performs as expected during automated calculation of the eCQM.
    • Plan for future use and discussion of how the measures will be useful for accountability and improvement.
    • Identification of related and competing measures with a plan for harmonization or justification for developing a competing measure.

    Once eCQM candidates have completed a successful screening, they may be submitted via online Measure Submission Form for committee consideration in the Trial Use Program.

    Maintenance of eCQM Trial Approval Program

    Trial Approval designation expires three years after the initial committee approval date (if the eCQM has not been submitted for endorsement prior to that date).

    • There is no expectation that every trial approval measure will be submitted for endorsement consideration – some may fail during testing.
    • If submitted for endorsement three or more years after the Trial Approval date, the measure must be submitted and evaluated on all criteria similar to any measure being submitted for initial endorsement consideration.

    Trial Approval measures may be submitted for endorsement at any time prior to the three-year expiration. There are two options for endorsement evaluation:

    • Option 1: Submit for the evaluation of only the Scientific Acceptability of Measure Properties criterion, including the final eCQM specification and all testing. If endorsed, endorsement date will assume the Trial Approval date. Endorsement maintenance will be scheduled on the regular three-year cycle and the measure will be subject to evaluation on all criteria.
    • Option 2: Submit for evaluation on all criteria. If endorsed, an endorsement date will be identified and endorsement maintenance will be scheduled from the endorsement date, at which time it will be submitted for endorsement maintenance and subject to evaluation on all criteria.